Revolution Medicines (NasdaqGS:RVMD) 2025 Conference November 18, 2025 04:30 AM ET Company ParticipantsMark Goldsmith - CEOConference Call ParticipantsClara Dunn - Biotech AnalystClara DunnHey, good morning, everyone. Let's get started. Welcome for joining us for Jefferies London Healthcare Conference. My name is Clara Dunn, a biotech analyst here at Jefferies. So sitting next to me, we have the Chief Executive Officer of Revolution Medicines, Mark Goldsmith. Welcome, Mark.Mark GoldsmithThank you.Clara Dunn ...